Back
ThreeD Capital Vs. Monopar Therapeutics Industry Stock Comparison
Buy
57
IDK.CX
ThreeD Capital
Last Price:
0.25
Seasonality Move:
36.18%
Buy
65
MNPR
Monopar Therapeutics
Last Price:
19.10
Seasonality Move:
7.43%
Buy
57
ThreeD Capital (IDK.CX)
is a Buy
Is ThreeD Capital a Buy, Sell or Hold?
- The current ThreeD Capital [IDK.CX] share price is $0.25. The Score for IDK.CX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- IDK.CX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
- The current Monopar Therapeutics [MNPR] share price is $32.66. The Score for MNPR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- MNPR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IDK.CX Stock Price Chart
What is ThreeD Capital's stock price today?
-
The ThreeD Capital share price today is $0.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IDK.CX is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $32.66
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
IDK.CX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 47.86 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.24 - 0.26) | Sell |
Bollinger Bands (100): | (0.25 - 0.33) | Sell |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.46 | Buy |
Relative Strength Index (14 RSI): | 93.57 | Buy |
Chaikin Money Flow: | 12436621 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.85 - 11.69) | Buy |
Bollinger Bands (100): | (0.99 - 7.11) | Buy |
IDK.CX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.25 | Sell |
20-day SMA: | 0.25 | Buy |
50-day SMA: | 0.26 | Sell |
200-day SMA: | 0.35 | Sell |
8-day EMA: | 0.25 | Sell |
20-day EMA: | 0.25 | Sell |
50-day EMA: | 0.27 | Sell |
200-day EMA: | 0.32 | Sell |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.64 | Buy |
20-day SMA: | 6.69 | Buy |
50-day SMA: | 4.51 | Buy |
200-day SMA: | 3.61 | Buy |
8-day EMA: | 11.25 | Buy |
20-day EMA: | 7.63 | Buy |
50-day EMA: | 5.48 | Buy |
200-day EMA: | 4.09 | Buy |
ThreeD Capital Earnings Growth & IDK.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.34 per share, and a decrease next year of $0.21 per share.
ThreeD Capital Technical Analysis
Oct 9 | Oct 10 | Oct 11 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
09 | 10 | 11 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |